ERNA vs SAP
Eterna Therapeutics Inc (ERNA) versus SAP (SAP) — a side-by-side from cached financials, not a winner call.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
SAP (SAP) common stock.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
SAP does not have a complete income-statement cache yet.
ERNA currently screens at market cap $6.9M and trailing P/E 0.0. SAP currently screens at market cap $0.
Not investment advice. Open the ERNA and SAP stock pages for the full models.
Not investment advice.